Avoro Capital Advisors LLC
CIK 1633313 · last filed 2026-07-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
6
Total Filings
26
Lifetime Open-Market Net
$238.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCTX | Director | — | — | — | $0 | 1 | 2026-07-27 |
| WHWK | Director | — | $4.47 | — | $0 | 3 | 2026-06-15 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | Director | 3,471,752 | $2.05 | $7.12M | $0 | 4 | 2025-03-04 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | 10%+ Owner | — | $32.48 | — | $0 | 3 | 2023-09-14 |
| IMMUNOMEDICS INC (IMMU) Delisted | Director | 26,267,234 | — | — | $288.76M | 13 | 2020-06-22 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | 10%+ Owner | 3,800,000 | $58.70 | $223.06M | -$50.02M | 2 | 2019-07-25 |
Recent Filings · Page 2 of 3
26 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-23 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Buy (P) | — | $0 | EDGAR |
| 2020-06-22 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | +7,436 | $0 | EDGAR |
| 2020-05-01 | IMMUNOMEDICS INC (IMMU) Delisted | Buy (P) | +3,500,000 | $99.75M | EDGAR |
| 2019-12-09 | IMMUNOMEDICS INC (IMMU) Delisted | Buy (P) | +4,000,000 | $70.00M | EDGAR |
| 2019-11-20 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-10-04 | IMMUNOMEDICS INC (IMMU) Delisted | Buy (P) | +3,000,000 | $40.56M | EDGAR |
| 2019-07-25 | Mirati Therapeutics, Inc. (MRTX) Delisted | Sell (S) | −125,000 | -$12.73M | EDGAR |
| 2019-06-28 | IMMUNOMEDICS INC (IMMU) Delisted | Buy (P) | +2,000,000 | $27.10M | EDGAR |
| 2019-06-11 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | +19,334 | $0 | EDGAR |
| 2019-06-05 | IMMUNOMEDICS INC (IMMU) Delisted | Buy (P) | +3,071,078 | $37.49M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.